Article: Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day.

- Focalin XR demonstrated better symptom control versus Concerta from 30 minutes to six hours post-dose in primary and secondary endpoints

- Only Focalin XR provided onset of effect as early as 30 minutes post-dose

- Additional analysis suggests Focalin XR provides comparable efficacy to Concerta over 12 hours

- Symptoms of Attention Deficit/Hyperactivity Disorder (ADHD) can significantly impact a child's ability to focus and learn in an educational setting

EAST HANOVER, N.J., July 8 /PRNewswire/ -- A head-to-head study, published in the June Journal of Child and Adolescent Psychopharmacology, confirms that Focalin(R) XR ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!